not losing weight on 2.5 tirzepatide Why Am I Tirzepatide? Average weight loss and results

Treatment starts at 0.25 mg weekly and increases every four weeks through 0.5 mg, 1.0 mg, and 1.7 mg before reaching the maintenance dose of 2.4 mg per week

Recombinant biotinylated human FcRn (Immunitrack) (1 g/mL) was immobilized (~100 RU) on a Sensor Chip SA (Cytiva), following the manufacturers protocol

Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK

It brings elasticity to the skin

I am bigger than other people

Thigh vs abdomen vs upper arm: which site is best